Sign in

CIK 0001645113

  • Large accelerated filer

NovoCure Ltd

Sign in to watch
Ticker
NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
Phone
+44 1534756700
Business address
NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
  1. 4 Open-market sale Chief Medical Officer sold 5,958 shares at $200.00 ($1,191,600)
  2. 4/A Open-market sale Chief Science Officer sold 2,835 shares at $140.00 ($396,900)
  3. 4 Open-market sale Chief Operating Officer sold 3,670 shares at $72.22 ($265,029)
  4. 4 Open-market sale Executive Chairman sold 7,928 shares at $134.12 ($1,063,303)
  5. 4 Open-market sale Chief Science Officer sold 3,892 shares at $140.00 ($544,880)
  6. 4 Open-market sale Chief Commercial Officer sold 6,151 shares at an average $130.97 ($805,589)
  7. 4 Open-market sale Chief Financial Officer sold 765 shares at $130.81 ($100,067)
  8. 4 Open-market sale General Counsel sold 2,404 shares at $130.81 ($314,458)
  9. 4 Open-market sale Chief Development Officer sold 765 shares at $130.81 ($100,067)
  10. 4 Open-market sale Chief Operating Officer sold 3,004 shares at $130.81 ($392,941)
  11. 4 Open-market sale Chief Commercial Officer sold 4,550 shares at $131.53 ($598,462)
  12. 4 Open-market sale Chief Medical Officer sold 2,918 shares at $131.53 ($383,805)
  13. 4 Open-market sale Chief Operating Officer sold 3,854 shares at $137.55 ($530,133)
  14. 4 Open-market sale General Counsel sold 3,084 shares at $137.55 ($424,217)
  15. 4 Open-market sale Chief Development Officer sold 567 shares at $137.55 ($77,993)
  16. 4 Open-market sale Chief Financial Officer sold 567 shares at $137.55 ($77,993)
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 16 of 39 · 780 filings